ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Personalized Care Key as Tirzepatide Use Expands Rapidly"
Episode Synopsis
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes. Overall, their findings show a significant uptick in tirzepatide dispensations, alongside other glucose- and weight-lowering medications, including semaglutide.
In God we trust